Literature DB >> 19406944

In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR) beta in TRbeta E457A knock-in and SRC-1 knockout mice.

Manuela Alonso1, Charles Goodwin, Xiaohui Liao, Tania Ortiga-Carvalho, Danielle S Machado, Fredric E Wondisford, Samuel Refetoff, Roy E Weiss.   

Abstract

The activation function-2 (AF-2) domain of the thyroid hormone (TH) receptor (TR)-beta is a TH-dependent binding site for nuclear coactivators (NCoA), which modulate TH-dependent gene transcription. In contrast, the putative AF-1 domain is a TH-independent region interacting with NCoA. We determined the specificity of the AF-2 domain and NCoA interaction by evaluating thyroid function in mice with combined disruption of the AF-2 domain in TRbeta, due to a point mutation (E457A), and deletion of one of the NCoAs, steroid receptor coactivator (SRC)-1. The E457A mutation was chosen because it abolishes NCoA recruitment in vitro while preserving normal TH binding and corepressor interactions resulting in resistance to TH. At baseline, disruption of SRC-1 in the homozygous knock-in (TRbeta(E457A/E457A)) mice worsened the degree of resistance to TH, resulting in increased serum T(4) and TSH. During TH deprivation, disruption of AF-2 and SRC-1 resulted in a TSH rise 50% of what was seen when AF-2 alone was removed, suggesting that SRC-1 was interacting outside of the AF-2 domain. Therefore, 1) during TH deprivation, SRC-1 is necessary for activating the hypothalamic-pituitary-thyroid axis; 2) ligand-dependent repression of TSH requires an intact AF-2; and 3) SRC-1 may interact with the another region of the TRbeta or the TRalpha to regulate TH action in the pituitary. This report demonstrates the dual interaction of NCoA in vivo: the TH-independent up-regulation possibly through another domain and TH-dependent down-regulation through the AF-2 domain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406944      PMCID: PMC2717870          DOI: 10.1210/en.2009-0093

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  45 in total

1.  A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms.

Authors:  M E Meyer; C Quirin-Stricker; T Lerouge; M T Bocquel; H Gronemeyer
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

2.  Negative regulation of the glycoprotein hormone alpha gene promoter by thyroid hormone: mutagenesis of a proximal receptor binding site preserves transcriptional repression.

Authors:  L D Madison; J A Ahlquist; S D Rogers; J L Jameson
Journal:  Mol Cell Endocrinol       Date:  1993-07       Impact factor: 4.102

3.  Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor.

Authors:  M V Govindan; N Warriar
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

4.  Ligand-induced recruitment of a histone deacetylase in the negative-feedback regulation of the thyrotropin beta gene.

Authors:  S Sasaki; L A Lesoon-Wood; A Dey; T Kuwata; B D Weintraub; G Humphrey; W M Yang; E Seto; P M Yen; B H Howard; K Ozato
Journal:  EMBO J       Date:  1999-10-01       Impact factor: 11.598

5.  Multiple and cooperative trans-activation domains of the human glucocorticoid receptor.

Authors:  S M Hollenberg; R M Evans
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

6.  Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.

Authors:  J Xu; Y Qiu; F J DeMayo; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Science       Date:  1998-03-20       Impact factor: 47.728

7.  Steroid receptor coactivator-1 deficiency causes variable alterations in the modulation of T(3)-regulated transcription of genes in vivo.

Authors:  Yoko Takeuchi; Yoshiharu Murata; Peter Sadow; Yoshitaka Hayashi; Hisao Seo; Jianming Xu; Bert W O'Malley; Roy E Weiss; Samuel Refetoff
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

8.  Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone.

Authors:  T Tagami; L D Madison; T Nagaya; J L Jameson
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

9.  Functional analysis of a transactivation domain in the thyroid hormone beta receptor.

Authors:  Y Tone; T N Collingwood; M Adams; V K Chatterjee
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

10.  Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation.

Authors:  E M McInerney; B S Katzenellenbogen
Journal:  J Biol Chem       Date:  1996-09-27       Impact factor: 5.157

View more
  15 in total

1.  The nuclear receptor corepressor (NCoR) controls thyroid hormone sensitivity and the set point of the hypothalamic-pituitary-thyroid axis.

Authors:  Inna Astapova; Kristen R Vella; Preeti Ramadoss; Kaila A Holtz; Benjamin A Rodwin; Xiao-Hui Liao; Roy E Weiss; Michael A Rosenberg; Anthony Rosenzweig; Anthony N Hollenberg
Journal:  Mol Endocrinol       Date:  2011-01-14

Review 2.  Thyroid disrupting chemicals and developmental neurotoxicity - New tools and approaches to evaluate hormone action.

Authors:  Katherine L O'Shaughnessy; Mary E Gilbert
Journal:  Mol Cell Endocrinol       Date:  2019-11-21       Impact factor: 4.102

3.  Synthesis and evaluation of methylsulfonylnitrobenzamides (MSNBAs) as inhibitors of the thyroid hormone receptor-coactivator interaction.

Authors:  Jong Yeon Hwang; Ramy R Attia; Angela K Carrillo; Michele C Connelly; R Kiplin Guy
Journal:  Bioorg Med Chem Lett       Date:  2013-01-08       Impact factor: 2.823

Review 4.  Thyroid hormone receptors and resistance to thyroid hormone disorders.

Authors:  Tânia M Ortiga-Carvalho; Aniket R Sidhaye; Fredric E Wondisford
Journal:  Nat Rev Endocrinol       Date:  2014-08-19       Impact factor: 43.330

5.  Variable clinical presentation and outcome in pediatric patients with resistance to thyroid hormone (RTH).

Authors:  Ana Chiesa; Maria Cecilia Olcese; Patricia Papendieck; Alicia Martinez; Ana Vieites; Sonia Bengolea; Héctor Manuel Targovnik; Carina Marcela Rivolta; Carina Maria Rivolta; Laura Gruñeiro-Papendieck
Journal:  Endocrine       Date:  2011-08-26       Impact factor: 3.633

6.  Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone.

Authors:  Jong Yeon Hwang; Wenwei Huang; Leggy A Arnold; Ruili Huang; Ramy R Attia; Michele Connelly; Jennifer Wichterman; Fangyi Zhu; Indre Augustinaite; Christopher P Austin; James Inglese; Ronald L Johnson; R Kiplin Guy
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

7.  Novel mechanism of positive versus negative regulation by thyroid hormone receptor β1 (TRβ1) identified by genome-wide profiling of binding sites in mouse liver.

Authors:  Preeti Ramadoss; Brian J Abraham; Linus Tsai; Yiming Zhou; Ricardo H Costa-e-Sousa; Felix Ye; Martin Bilban; Keji Zhao; Anthony N Hollenberg
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

8.  Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors.

Authors:  Kristen R Vella; Preeti Ramadoss; Ricardo H Costa-E-Sousa; Inna Astapova; Felix D Ye; Kaila A Holtz; Jamie C Harris; Anthony N Hollenberg
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

9.  Pressure regulated basis for gene transcription by delta-cell micro-compliance modeled in silico: Biphenyl, bisphenol and small molecule ligand models of cell contraction-expansion.

Authors:  Hemant Sarin
Journal:  PLoS One       Date:  2020-10-06       Impact factor: 3.240

Review 10.  Mechanisms of thyroid hormone action.

Authors:  Gregory A Brent
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.